Alectinib hydrochloride is a hydrochloride salt form of alectinib, a selective inhibitor of anaplastic lymphoma kinase (ALK). It is used as a pharmaceutical raw material for the manufacturing of medications indicated for ALK-positive metastatic non-small cell lung cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1256589-74-8
Alectinib
pharmaceutical raw material
8-azaguanine
pharmaceutical raw material
Chimmitecan
pharmaceutical raw material
Ixabepilone
pharmaceutical raw material
Duocarmycin DM free base
pharmaceutical raw material
Boceprevir
pharmaceutical raw material
Prochlorperazine edisylate
pharmaceutical raw material
Venetoclax
pharmaceutical raw material
9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile;hydrochloride
GYABBVHSRIHYJR-UHFFFAOYSA-N
CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C.Cl